Search news stories
Enter a keyword to search news.
Dr Amy Dwyer publishes paper in the British Journal of Cancer on a role for IGF/insulin in breast cancer
Dr Amy Dwyer was first author on a paper recently published in BJC entitled "Insulin receptor substrate-1 (IRS-1) mediates progesterone receptor–driven stemness and endocrine resistance in oestrogen receptor+ breast cancer". Amy’s work for this paper was undertaken during her postdoctoral appointment at The Masonic Cancer Center, University of Minnesota, Minneapolis, USA. Well done Amy!
PhD student Danielle Fang was awarded an Innovation and Commercial Partners Prize at the 2020 Virtual Florey Postgraduate Research Conference in October, 2020. Her poster was entitled "USP2: A key driver in lethal prostate cancer?" In November 2020, PhD student Ebithal Mustafa was awarded the Australian Women in Endocrinology Prize at the 63rd ESA Annual Scientific meeting (virtual). Her poster entitled "TFAP-2β interacts with AR to determine the phenotype and growth of molecular apocrine breast cancer" was the highest ranked science poster in the e-poster award finalist group. Congratulations to Danielle and Ebi!
Dr Jean Winter gave a presentation on "Advances and challenges of high-throughput 3D imaging using patient derived samples" as related to her breast cancer research, at the symposium organised by the South Australian Cancer Research Institute / University of South Australia. This focused symposium attracted more than 110 participants from 17 universities and research institutes across the country. Models and enabling technologies featured in the program were prostate cancer explants, and organoids derived from liver, nasal cells, ovary, breast and bowel cancer.
It's great to see that nothing can stop us from having our walk/run for @MDC_walk_run 2020! Thanks everyone for virtually participating to support breast cancer research and awareness in the Women in Super Mother's Day Classic annual event! Together we are strong!
Movember- National Breast Cancer Foundation Collaborative Linkage Program engagement meeting held in Sydney
Our Collaborative Linkage grant team members met in Sydney on 10 March 2020 to showcase and discuss the progress on our research program in "Transforming endocrine therapy for breast and prostate cancer". Representatives from each of the project’s node at the University of Adelaide, Monash University and the Garvan Institute attended in person or via teleconference, as did our funding sponsors, Movember and NBCF, and some of our consumer advocates.
Nuclear receptors are critical determinants of everyday health. They drive key processes at every stage from development and reproduction to ageing and cancer. Professor Tilley was Co-Convenor and Chairperson at this year’s meeting which had the theme of "New Roles for Nuclear Receptors in Development, Health and Disease". The 2020 meeting brought together many of the leading experts in nuclear receptor research from across the globe to generate meaningful idea exchanges and interactions that will help to further shape this influential field.
Congratulations to Rayzel Fernandes on the conferral of her doctoral degree entitled “The role of microRNA-194 in prostate cancer progression”. Rayzel’s project was supported by an International Postgraduate Research Scholarship/ Australian Postgraduate Award, as well as a Freemason’s Foundation Centre for Men’s Health PhD Scholarship top-up award. Rayzel will be leaving the DRMCRL to take up a post-doctoral position at Imperial College London.
The 15th Indo-Australian Biotechnology Conference, held biennially in Australia, was hosted by the DRMCRL on 16-18 November in Adelaide.
The DRMCRL is excited to announce we have been awarded an NHMRC Ideas Grant for funding commencing in 2020. Professor Wayne Tilley will be the PI for the project entitled “A combinatorial drug strategy to target lethal forms of breast cancer” which will address a critical unmet need by combining new treatment strategies in the most lethal forms of breast cancer.
Dr Winter was invited to present her work on “High throughput drug screening in breast and prostate cancer using an innovative cell morphology-based analytical pipeline” at the 10th Functional High Throughput Technologies Australia meeting held at the John Curtin School of Medical Research, ANU, Canberra on 30-31 October.